Biote Corp. Confirms Nasdaq Listing and Corporate Details in 8-K

TL;DR

**Biote Corp. filed a routine 8-K confirming its Nasdaq listing and updated corporate info.**

AI Summary

On January 25, 2024, biote Corp. (BTMD) filed an 8-K to update its registration information, specifically confirming its Class A common stock, par value $0.0001 per share, is registered on The Nasdaq Stock Market LLC under the trading symbol BTMD. This filing primarily serves to ensure compliance with SEC regulations and provides current corporate details, including its address at 1875 W. Walnut Hill Ln #100, Irving, Texas 75038. For investors, this matters because it reaffirms the company's listing status and provides up-to-date contact information, which is crucial for transparency and regulatory adherence.

Why It Matters

This filing ensures biote Corp. remains compliant with SEC regulations and provides current, accurate information to investors, reinforcing transparency and trust in its public listing.

Risk Assessment

Risk Level: low — This is a routine administrative filing with no new material financial or operational information that would introduce significant risk.

Analyst Insight

This filing is administrative and does not warrant immediate action. Investors should continue to monitor for filings containing material financial or operational updates.

Key Numbers

• $0.0001 — Par Value per Share (The par value of biote Corp.'s Class A common stock.)

Key Players & Entities

• biote Corp. (company) — the registrant filing the 8-K
• The Nasdaq Stock Market LLC (company) — the exchange where biote Corp.'s stock is registered
• BTMD (company) — the trading symbol for biote Corp.'s Class A common stock
• $0.0001 (dollar_amount) — par value per share of Class A common stock
• January 25, 2024 (date) — date of earliest event reported and filing date

Forward-Looking Statements

• biote Corp. will continue to maintain its listing on The Nasdaq Stock Market LLC. (biote Corp.) — high confidence, target: 2025-01-25
• The company's corporate contact information will remain consistent for the foreseeable future. (biote Corp.) — high confidence, target: 2024-12-31

FAQ

Key Financial Figures

• $0.0001 — stered Class A common stock, par value $0.0001 per share BTMD The Nasdaq Stock Mar
• $20 million — new stock repurchase program for up to $20 million of the Company's Class A common stock.

Filing Documents

• d749889d8k.htm (8-K) — 23KB
• d749889dex991.htm (EX-99.1) — 8KB
• g749889g0125070022265.jpg (GRAPHIC) — 3KB
• 0001193125-24-015456.txt ( ) — 157KB
• btmd-20240125.xsd (EX-101.SCH) — 3KB
• btmd-20240125_lab.xml (EX-101.LAB) — 18KB
• btmd-20240125_pre.xml (EX-101.PRE) — 11KB
• d749889d8k_htm.xml (XML) — 3KB

01

Item 8.01 Other Events. On January 25, 2024, biote Corp., a Delaware corporation (the "Company") issued a press release announcing that the board of directors of the Company has approved a new stock repurchase program for up to $20 million of the Company's Class A common stock. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release, dated January 25, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). SIGNATURE Pursuant to the requirements of the Exchange Act, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. biote Corp. By: /s/ Teresa S. Weber Name: Teresa S. Weber Title: Chief Executive Officer Date: January 25, 2024

View Full Filing

View this 8-K filing on SEC EDGAR